A detailed history of Nine Point Two Capital LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Nine Point Two Capital LLC holds 7,879 shares of TMDX stock, worth $532,226. This represents 0.25% of its overall portfolio holdings.

Number of Shares
7,879
Holding current value
$532,226
% of portfolio
0.25%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$36.74 - $81.08 $289,474 - $638,829
7,879 New
7,879 $621,000
Q2 2023

Aug 14, 2023

BUY
$66.23 - $88.73 $224,718 - $301,060
3,393 New
3,393 $284,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.15B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Nine Point Two Capital LLC Portfolio

Follow Nine Point Two Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nine Point Two Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nine Point Two Capital LLC with notifications on news.